224 related articles for article (PubMed ID: 35881422)
1. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
3. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
[TBL] [Abstract][Full Text] [Related]
5. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice.
Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H
Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338
[TBL] [Abstract][Full Text] [Related]
6. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
7. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
[TBL] [Abstract][Full Text] [Related]
10. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.
Sun X; Sun P; Zhen D; Xu X; Yang L; Fu D; Wei C; Niu X; Tian J; Li H
Toxicol Appl Pharmacol; 2022 Feb; 437():115902. PubMed ID: 35093381
[TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes.
Mao M; Zheng W; Deng B; Wang Y; Zhou D; Shen L; Niku W; Zhang N
PLoS One; 2023; 18(10):e0292124. PubMed ID: 37824478
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
13. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.
Zhang J; Li W; Xue S; Gao P; Wang H; Chen H; Hong Y; Sun Q; Lu L; Wang Y; Wang Q
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117134. PubMed ID: 37714227
[TBL] [Abstract][Full Text] [Related]
14. Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1.
Meng P; Chen Z; Sun T; Wu L; Wang Y; Guo T; Yang J; Zhu J
Aging (Albany NY); 2023 Sep; 15(19):10133-10145. PubMed ID: 37770231
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
16. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis.
Liao HH; Ding W; Zhang N; Zhou ZY; Ling Z; Li WJ; Chen S; Tang QZ
Free Radic Biol Med; 2023 Aug; 205():275-290. PubMed ID: 37331642
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
[TBL] [Abstract][Full Text] [Related]
18. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A alleviates ferroptosis in doxorubicin-induced cardiotoxicity via the PI3K/AKT/MDM2/p53 pathway.
Chen G; Luo S; Guo H; Lin J; Xu S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4247-4262. PubMed ID: 38078919
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Na
Leng B; Deng L; Tan J; Lee WT; Cao CR; Wang ZP; Huang DJ; Nie X; Bian JS
Free Radic Biol Med; 2023 Aug; 204():38-53. PubMed ID: 37100355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
